Characterization of the tautomeric equilibrium of molnupiravir, an antiviral for the treatment of COVID-19.
Saved in:
| Title: | Characterization of the tautomeric equilibrium of molnupiravir, an antiviral for the treatment of COVID-19. |
|---|---|
| Authors: | Burgess SA; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA. Electronic address: samantha.burgess@merck.com., Wang X; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Stueber D; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Wang Y; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Cohen RD; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA., Lam YH; Modeling & Informatics, Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA., Iuzzolino L; Modeling & Informatics, Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA., Reibarkh M; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ 07065, USA. Electronic address: mikhail_reibarkh@merck.com. |
| Source: | Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2025 Nov 15; Vol. 265, pp. 117025. Date of Electronic Publication: 2025 Jun 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
